Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury

Markoutsa, E., K. Mayilsamy, D. Gulick, S. S. Mohapatra, and S. Mohapatra. 2022. Treatment With ShCCL20-CCR6 Nanodendriplexes and Human Mesenchymal Stem Cell Therapy Improves Pathology in Mice With Repeated Traumatic Brain Injury.
Last updated on 05/24/2024